Cargando…

Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome

The vascular type of Ehlers–Danlos syndrome (EDS), EDS type IV (Online Mendelian Inheritance in Man [MIM] #130050) is characterized by thin, translucent skin, easy bruising, and arterial, intestinal, and/or uterine fragility during pregnancy, which may lead to sudden death. It is an autosomal domina...

Descripción completa

Detalles Bibliográficos
Autores principales: Naing, Banyar Than, Watanabe, Atsushi, Tanigaki, Shinji, Ono, Masae, Iwashita, Mitsutoshi, Shimada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069127/
https://www.ncbi.nlm.nih.gov/pubmed/24971038
http://dx.doi.org/10.2147/IMCRJ.S59879
_version_ 1782322514202984448
author Naing, Banyar Than
Watanabe, Atsushi
Tanigaki, Shinji
Ono, Masae
Iwashita, Mitsutoshi
Shimada, Takashi
author_facet Naing, Banyar Than
Watanabe, Atsushi
Tanigaki, Shinji
Ono, Masae
Iwashita, Mitsutoshi
Shimada, Takashi
author_sort Naing, Banyar Than
collection PubMed
description The vascular type of Ehlers–Danlos syndrome (EDS), EDS type IV (Online Mendelian Inheritance in Man [MIM] #130050) is characterized by thin, translucent skin, easy bruising, and arterial, intestinal, and/or uterine fragility during pregnancy, which may lead to sudden death. It is an autosomal dominant inherited disorder caused by type III procollagen gene (COL3A1: MIM #120180) mutations. Approximately 50% of the COL3A1 mutations are inherited from an affected parent, and 50% are de novo mutations. Each child of an affected individual has a 50% chance of inheriting the mutation and developing the disorder. Pregnant women with vascular EDS are at an increased risk of uterine and arterial rupture during the peripartum period, with high maternal morbidity and mortality rates. We report the first case of an asymptomatic 35-year-old woman at a risk of complications of vascular EDS who underwent presymptomatic evaluation during pregnancy. The sequencing results of both her brother and mother had a one-base-pair deletion, resulting in Glutamate at position 730 changing to Lysine and causing a frame shift and premature termination codon at 61 amino acids from the mutation position (p. Glu730Lysfs*61) on exon 32 of COL3A1. This deletion caused frameshift, leading to a premature termination codon (TAG) at 181 nucleotides downstream in exon 35, which could not be detected by previous total RNA (ribonucleic acid) method. Thus, she was at risk of complications of vascular EDS, and diagnostic testing was employed at 8 weeks of pregnancy to minimize the risk of developing vascular EDS-related complications. The negative presymptomatic diagnostic result allowed the patient to choose normal delivery at term. Vascular EDS is a serious disorder, with high mortality, especially in high-risk women with vascular EDS during pregnancy. The presymptomatic genetic testing of vascular EDS during pregnancy for a high-risk family can help with the early establishment of preventive measures.
format Online
Article
Text
id pubmed-4069127
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-40691272014-06-26 Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome Naing, Banyar Than Watanabe, Atsushi Tanigaki, Shinji Ono, Masae Iwashita, Mitsutoshi Shimada, Takashi Int Med Case Rep J Case Report The vascular type of Ehlers–Danlos syndrome (EDS), EDS type IV (Online Mendelian Inheritance in Man [MIM] #130050) is characterized by thin, translucent skin, easy bruising, and arterial, intestinal, and/or uterine fragility during pregnancy, which may lead to sudden death. It is an autosomal dominant inherited disorder caused by type III procollagen gene (COL3A1: MIM #120180) mutations. Approximately 50% of the COL3A1 mutations are inherited from an affected parent, and 50% are de novo mutations. Each child of an affected individual has a 50% chance of inheriting the mutation and developing the disorder. Pregnant women with vascular EDS are at an increased risk of uterine and arterial rupture during the peripartum period, with high maternal morbidity and mortality rates. We report the first case of an asymptomatic 35-year-old woman at a risk of complications of vascular EDS who underwent presymptomatic evaluation during pregnancy. The sequencing results of both her brother and mother had a one-base-pair deletion, resulting in Glutamate at position 730 changing to Lysine and causing a frame shift and premature termination codon at 61 amino acids from the mutation position (p. Glu730Lysfs*61) on exon 32 of COL3A1. This deletion caused frameshift, leading to a premature termination codon (TAG) at 181 nucleotides downstream in exon 35, which could not be detected by previous total RNA (ribonucleic acid) method. Thus, she was at risk of complications of vascular EDS, and diagnostic testing was employed at 8 weeks of pregnancy to minimize the risk of developing vascular EDS-related complications. The negative presymptomatic diagnostic result allowed the patient to choose normal delivery at term. Vascular EDS is a serious disorder, with high mortality, especially in high-risk women with vascular EDS during pregnancy. The presymptomatic genetic testing of vascular EDS during pregnancy for a high-risk family can help with the early establishment of preventive measures. Dove Medical Press 2014-06-19 /pmc/articles/PMC4069127/ /pubmed/24971038 http://dx.doi.org/10.2147/IMCRJ.S59879 Text en © 2014 Naing et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
Naing, Banyar Than
Watanabe, Atsushi
Tanigaki, Shinji
Ono, Masae
Iwashita, Mitsutoshi
Shimada, Takashi
Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title_full Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title_fullStr Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title_full_unstemmed Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title_short Presymptomatic genetic analysis during pregnancy for vascular type Ehlers–Danlos syndrome
title_sort presymptomatic genetic analysis during pregnancy for vascular type ehlers–danlos syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069127/
https://www.ncbi.nlm.nih.gov/pubmed/24971038
http://dx.doi.org/10.2147/IMCRJ.S59879
work_keys_str_mv AT naingbanyarthan presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome
AT watanabeatsushi presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome
AT tanigakishinji presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome
AT onomasae presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome
AT iwashitamitsutoshi presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome
AT shimadatakashi presymptomaticgeneticanalysisduringpregnancyforvasculartypeehlersdanlossyndrome